Sure you do! He's in prison now, but back in 2015, not long after becoming the chief executive officer of Turing Pharmaceuticals, the 32-year-old Shkreli jacked up the price of an important HIV drug, Daraprim, by more than 5,000 per cent.
Loading...
Bloomberg
Joe Nocera is a Bloomberg columnist and former editorial director of Fortune.